IHS Chemical Week

People & Business :: People/Executives

AMRI appoints William Marth as board chairman

4:39 AM MDT | June 6, 2013 | Deepti Ramesh

Albany Molecular Research Inc. (AMRI; Albany, NY) says its board of directors has unanimously voted to separate the role of chairman and CEO and has named William Marth, an active member of the AMRI board, as chairman of the board, effective 5 June 2013. The position of chairman has been held by Thomas D'Ambra, since the company's founding. D'Ambra retains his roles as a member of the board, president, and CEO. Marth was appointed to the AMRI board in 2012.  Marth, formerly president and CEO of Teva – Americas, retired from Teva in 2012. He had...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa